Impact of carboplatin hypersensitivity and desensitization on overall survival in patients with recurrent ovarian cancer

被引：0
|
作者：
Altwerger, G. [1 ]
Han, C. [1 ]
Zeybek, B. [1 ]
Haines, K. [1 ]
Gressel, G. M. [2 ]
Huang, G. S. [1 ]
Litkouhi, B. [1 ]
Azodi, M. [1 ,3 ,4 ]
Silasi, D. A. [1 ]
Santin, A. D. [1 ]
Schwartz, P. E. [1 ]
Ratner, E. S. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
[3] Yale, Smilow Canc Hosp, New Haven, CT USA
[4] Yale Univ, New Haven, CT USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.069
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
53
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [41] Risk stratification for desensitization of patients with carboplatin hypersensitivity: Clinical presentation and management
    Hesterberg, Paul E.
    Banerji, Aleena
    Oren, Eyal
    Penson, Richard T.
    Krasner, Carolyn N.
    Seiden, Michael V.
    Wong, Johnson T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (06) : 1262 - 1267
  • [42] Carboplatin hypersensitivity reactions in patients with ovarian and peritoneal carcinoma
    Rose, PG
    Fusco, N
    Fluellen, L
    Rodriguez, M
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (05) : 365 - 368
  • [43] The impact of sarcopenia on overall survival in patients with ovarian cancer: A systematic review and meta-analysis
    Tandiono, Jeannette
    Jonatan, Charlotte Alyssia
    Chen, Sharon
    Marcella, Elizabeth
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2021, 32 : S299 - S299
  • [44] Impact of salvage surgery and radiotherapy on overall survival in patients with recurrent primary urethral cancer.
    Gakis, Georgios
    Morgan, Todd Matthew
    Daneshmand, Siamak
    Keegan, Kirk A.
    Clayman, Rebecca Helen
    Mischinger, Johannes
    Zaid, Harras B.
    Hrbacek, Jan
    Ali-El-Dein, Bedeir
    Galland, Sigolene
    Olugbade, Kola
    Rink, Michael
    Fristche, Hans-Martin
    Burger, Maximilian
    Chang, Sam
    Babjuk, Marek
    Thalmann, George N.
    Stenzl, Arnulf
    Efstathiou, Jason Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [45] Impact of nonspecific death on overall survival in early-stage epithelial ovarian cancer patients
    Dai, Danian
    Deng, Ting
    Wang, Bin
    Chen, Shangqiu
    Liu, Zhimin
    Luo, Xiaolin
    Wang, Feng
    Huang, He
    Liu, Jihong
    CURRENT PROBLEMS IN CANCER, 2021, 45 (01)
  • [46] Perioperative β blockade improves overall survival in patients with ovarian cancer
    Dickson, E. L.
    Karnowski, J.
    Saha, S.
    Albertin, C.
    McNally, A.
    Al-Niaimi, A. N.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 106 - 106
  • [47] Hypomagnesemia and Survival in Patients with Ovarian Cancer Who Received Chemotherapy with Carboplatin
    Liu, Wenli
    Qdaisat, Aiham
    Soliman, Pamela T.
    Ramondetta, Lois
    Lopez, Gabriel
    Narayanan, Santhosshi
    Zhou, Shouhao
    Cohen, Lorenzo
    Bruera, Eduardo
    Yeung, Sai-Ching J.
    ONCOLOGIST, 2019, 24 (06): : E312 - E317
  • [48] Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity
    Kandel, MJ
    Loehr, A
    Harter, P
    Traut, A
    Gnauert, K
    Du Bois, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (05) : 780 - 784
  • [49] Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer
    Hwang, Woo Yeon
    Lee, Minjung
    Suh, Dong Hoon
    Kim, Kidong
    No, Jae Hong
    Kim, Yong Beom
    Kim, Ju-Hyun
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (02) : 443 - 449
  • [50] Retreatment with nedaplatin in patients with recurrent gynecological cancer after the development of hypersensitivity reaction to carboplatin
    Arimoto, Takahide
    Oda, Katsutoshi
    Nakagawa, Shunsuke
    Kawana, Kei
    Tsukazaki, Takehiro
    Adachi, Katsuyuki
    Matsumoto, Yoko
    Yano, Tetsu
    Kozuma, Shiro
    Taketani, Yuji
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (01) : 336 - 340
12345